Skip to main content
XENE logo

XENE

Xenon Pharmaceuticals Inc.
$67.71 +0.41 (+0.61%) At close · Jul 15
Market Cap
$6.47B
Shares
96,665,550

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 295
Total Value: $6,024,693,619
Total Shares: 103,601,284
Showing 1–100 of 307 holdings by value · page 1 of 4

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 294 13F filers
Top Holder
10.4%
Jun 2023 → Mar 2026 · range 7.7% – 10.7%
of institutional value
Top 5
30.4%
Jun 2023 → Mar 2026 · range 30.4% – 33.3%
of institutional value
Top 10
45.9%
Jun 2023 → Mar 2026 · range 45.9% – 50.5%
of institutional value
HHI
308
Jun 2023 → Mar 2026 · range 308 – 358
Broadly held
Showing 100 of 307
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1582313 CUSIP 98420N105 13F (30d) 12 filings 12 filers Visit website Investor relations